ATE159658T1 - Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung - Google Patents

Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Info

Publication number
ATE159658T1
ATE159658T1 AT90902584T AT90902584T ATE159658T1 AT E159658 T1 ATE159658 T1 AT E159658T1 AT 90902584 T AT90902584 T AT 90902584T AT 90902584 T AT90902584 T AT 90902584T AT E159658 T1 ATE159658 T1 AT E159658T1
Authority
AT
Austria
Prior art keywords
patient
lipophilic
lollipop
compositions
desired effect
Prior art date
Application number
AT90902584T
Other languages
English (en)
Inventor
Theodore H Stanley
Brian Hague
Original Assignee
Univ Utah Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Research Inst filed Critical Univ Utah Research Inst
Application granted granted Critical
Publication of ATE159658T1 publication Critical patent/ATE159658T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90902584T 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung ATE159658T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs

Publications (1)

Publication Number Publication Date
ATE159658T1 true ATE159658T1 (de) 1997-11-15

Family

ID=22215208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902584T ATE159658T1 (de) 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Country Status (8)

Country Link
EP (1) EP0493380B1 (de)
JP (1) JP2758985B2 (de)
AT (1) ATE159658T1 (de)
AU (2) AU645966B2 (de)
DE (1) DE68928415T2 (de)
DK (1) DK175773B1 (de)
NO (2) NO920855L (de)
WO (1) WO1991003233A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (de) * 1977-08-05 1981-07-15 Battelle Memorial Institute
DK0745380T3 (da) * 1995-05-11 2005-12-05 Univ Utah Res Found Tobakserstatning
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
WO2007090113A2 (en) * 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
EP3200773B1 (de) 2014-10-01 2018-07-18 Oxytone Bioscience B.V. Im mund zerfallende feste pharmazeutische dosiereinheit mit partuskontrollsubstanz
ES2821822T3 (es) 2014-10-01 2021-04-27 Oxytone Bioscience B V Unidad de dosificación farmacéutica sólida desintegrante por vía oral que contiene una sustancia de control de partos
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
CA3138094A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
NO920855L (no) 1992-04-10
DK175773B1 (da) 2005-02-14
NO920854L (no) 1992-04-27
DE68928415D1 (de) 1997-12-04
AU6069794A (en) 1994-06-23
NO920854D0 (no) 1992-03-04
WO1991003233A1 (en) 1991-03-21
NO920855D0 (no) 1992-03-04
DK30092A (da) 1992-05-05
DE68928415T2 (de) 1998-02-26
EP0493380B1 (de) 1997-10-29
AU645966B2 (en) 1994-02-03
AU5035290A (en) 1991-04-08
EP0493380A4 (en) 1992-10-07
JP2758985B2 (ja) 1998-05-28
DK30092D0 (da) 1992-03-05
EP0493380A1 (de) 1992-07-08
JPH05501854A (ja) 1993-04-08

Similar Documents

Publication Publication Date Title
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
Kennedy et al. Intravenous regional analgesia: an appraisal
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE17079T1 (de) Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
NO891379D0 (no) Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav.
SG166294G (en) Inhalation medicaments for treating respiratory disorders
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
CA2070685C (en) Method for treating painful, inflammatory or allergic disorders
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
ATE159658T1 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE69004532T2 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
SU1659054A1 (ru) МЕСТНОЕ ПРОТИВОВОСПАЛИТЕЛЬНОЕ СРЕДСТВО "АЛОРОМ" 2
Sugai et al. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
EP0397211A3 (de) Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
Yaacob et al. The efficacy of xylocaine topical anaesthetic in reducing injection pain
JPS6442423A (en) Remedy containing propaphenone antipode
RU93034374A (ru) Лекарственный сбор для лечения ишемической болезни сердца, сопровождающейся выраженными невротическими реакциями
Suresh et al. Surgery in Siddha System

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties